Effects of Carotid Endarterectomy or Stenting on Blood Pressure in the International Carotid Stenting Study (ICSS)

Author:

Altinbas Aysun1,Algra Ale1,Brown Martin M.1,Featherstone Roland L.1,Kappelle L. Jaap1,de Borst Gert Jan1,Mali Willem P.Th.M.1,van der Worp H. Bart1

Affiliation:

1. From the Utrecht Stroke Center (A. Altinbas, A. Algra, L.J.K., H.B.v.d.W.), the Department of Neurology, Rudolf Magnus Institute of Neuroscience, the Julius Center for Health Sciences and Primary Care (A. Algra), Vascular Surgery (G.J.d.B.), and Radiology (W.P.T.M.M.), University Medical Center Utrecht, Utrecht, the Netherlands; and the Department of Brain Repair and Rehabilitation (M.M.B., R.L.F.), Institute of Neurology, University College London, London, UK.

Abstract

Background and Purpose— Arterial hypotension is more frequently observed early after carotid artery stenting (CAS) than after carotid endarterectomy (CEA), but their long-term effects on blood pressure (BP) are unclear. We compared the effects of CAS and CEA on BP up to 1 year after treatment in the International Carotid Stenting Study. Methods— Patients with symptomatic carotid stenosis were randomly allocated to CAS or CEA. Systolic and diastolic BP were recorded at baseline, at discharge, and at 1, 6, and 12 months. Antihypertensive medication use was recorded. A per-protocol analysis was performed. Patients with missing BP records were excluded. Between-group BP changes were compared and adjusted for baseline covariates with linear regression. Within-group BP changes were compared with the paired t test. Results— CAS (N=587) and CEA (N=637) were both associated with a decrease in BP at discharge, which was greater after CAS (mean difference in systolic BP between groups, 10.3 mm Hg; 95% CI, 7.3–13.3; P <0.0001; in diastolic BP, 4.1 mm Hg; 95% CI, 2.4–5.7; P <0.0001). During follow-up, BP changes were not different between groups. Adjustment for differences in baseline characteristics did not change the results. Fewer patients undergoing CAS used antihypertensive medication during follow-up than patients undergoing CEA (relative risk at 12 months, 0.91; 95% CI, 0.85–0.97; P =0.0073). Conclusions— CAS leads to a larger early decrease in BP than CEA, but this effect does not persist over time. CAS may lessen the requirement for antihypertensive medication more than CEA. Clinical Trial Registration— URL: www.controlled-trials.com . Unique identifier: ISRCTN25337470.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialised Nursing,Cardiology and Cardiovascular Medicine,Clinical Neurology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3